The American Business Television Network is a global streaming business channel broadcasting to our world-wide audience of investors and entrepreneurs. Financial news that helps private and institutional investors make informed decisions and market study analyses.
American Business TV promotes early stage technology innovation to domestic and foreign high-caliber investors and strategic partners. Investors watch American Business TV to see our exclusive content which includes early stage companies’ Pitch Promotion. These documentary-style Corporate Profile Pitch videos are shot on-location and feature CEO interviews and behind-the-scenes looks at your technology innovations. Your story and products will be broadcast to millions of viewers who are looking to buy, sell, invest, and enjoy investor-related content from the big-screen comfort of their homes or a variety of digital, and mobile platforms.
This Week on RedChip TV: 3 Small Cap Stocks Set for Rapid Growth
This week’s episode of the RedChip Money Report features interviews with senior executives of Aptorum Group (NASDAQ: APM), Esports Entertainment (NASDAQ: GMBL), and Milestone Scientific (NYSE AMERICAN: MLSS).
This week on the RedChip Money Report, watch exclusive interviews with senior executives of three top small cap stocks, Annovis Bio (NYSE AMERICAN: ANVS), SPI Energy (NASDAQ: SPI), and BioVie (OTCQB: BIV)
This week's episode features interviews with executives from three small-cap companies, SPI Energy (NASDAQ: SPI), a leading solar company globally with new higher-margin segments expected to drive near-term growth, Can-Fite BioPharma (NYSE American), a clinical-stage biotechnology company with tr...
Watch exclusive interviews with executives from top small-cap companies on this week's RedChip Money Report, featuring interview with Genetic Technologies (NASDAQ: GENE), Piedmont Lithium (NASDAQ: PLL), and MYnd Analytics (NASDAQ: MYND).
Watch exclusive interviews with executives from top small-cap companies on this week's RedChip Money Report, featuring interview with Wize Pharma, (OTCQB: WIZP) Nemaura Medical, (NASDAQ: NMRD) and Intellicheck (NYSE AMERICAN: IDN).